Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HTLV-II”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Post-approval studies (Phase 4)Study completedNCT03226119
What this trial is testing

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 150
Testing effectiveness (Phase 2)WithdrawnNCT01620736
What this trial is testing

Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load

Who this might be right for
Human T-cell Leukemia Virus Type 1 Infection
Washington University School of Medicine
Not applicableStudy completedNCT01149837
What this trial is testing

Evaluation of InnoLIA HTLV I/II Score

Who this might be right for
Human T-Lymphotrophic Virus Type I and/or Type II
Creative Testing Solutions 3,305
Not applicableStudy completedNCT00097006
What this trial is testing

Retrovirus Epidemiology Donor Study-II (REDS-II)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+10 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Not applicableStudy completedNCT01050881
What this trial is testing

Notification of Donors With Positive Microbiology Markers

Who this might be right for
Human Immunodeficiency VirusHepatitis BHepatitis C+2 more
NHS Blood and Transplant 217
Testing effectiveness (Phase 2)Study completedNCT02631746
What this trial is testing

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+3 more
National Cancer Institute (NCI) 3
Post-approval studies (Phase 4)Ended earlyNCT00854581
What this trial is testing

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

Who this might be right for
LymphomaPrecancerous/Nonmalignant Condition
University of Miami 13
Testing effectiveness (Phase 2)Study completedNCT00001941
What this trial is testing

Anti-Tac for Treatment of Leukemia

Who this might be right for
HTLV-I InfectionT Cell Leukemia
National Cancer Institute (NCI) 34
Not applicableUnknownNCT01467024
What this trial is testing

Evaluation of the MP Diagnostics HTLV Blot 2.4

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 600
Not applicableStudy completedNCT00005278
What this trial is testing

Retrovirus Epidemiology Donor Study I (REDS I)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+6 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Ended earlyNCT01712659
What this trial is testing

Ruxolitinib for Adult T-Cell Leukemia

Who this might be right for
T Cell Leukemia, AdultLeukemia, Adult T-CellT Cell Leukemia, HTLV I Associated
National Cancer Institute (NCI) 19